Of everything a CRC does, safety reporting carries the highest stakes. A missed adverse event, a late SAE report, or a miscategorized severity assessment can have direct consequences for participant safety and regulatory compliance. This course provides standalone, deep-dive training on the CRC's safety reporting responsibilities -- from recognizing that something has gone wrong, through documentation and grading, to timely reporting and follow-up. Safety reporting is too important to be a single module in a broader course. It deserves, and receives, its own dedicated curriculum.
28 lessons · 7 quizzes · 11 hours of content
Part of the Clinical Research Coordinator learning track
Explore the complete course structure before you enroll.
4 lessons · 180 min
1.1 Why safety reporting matters: from site reports to regulatory signals
Trace the path of adverse event reports from site documentation to regulatory signal detection, understanding why every CRC report matters for patient safety worldwide.
Create your free account to access the complete curriculum and knowledge assessments.
Of everything a CRC does, safety reporting carries the highest stakes. A missed adverse event, a late SAE report, or a miscategorized severity assessment can have direct consequences for participant safety and regulatory compliance. This course provides standalone, deep-dive training on the CRC's safety reporting responsibilities -- from recognizing that something has gone wrong, through documentation and grading, to timely reporting and follow-up. Safety reporting is too important to be a single module in a broader course. It deserves, and receives, its own dedicated curriculum.
28 lessons · 7 quizzes · 11 hours of content
Part of the Clinical Research Coordinator learning track
Explore the complete course structure before you enroll.
4 lessons · 180 min
1.1 Why safety reporting matters: from site reports to regulatory signals
Trace the path of adverse event reports from site documentation to regulatory signal detection, understanding why every CRC report matters for patient safety worldwide.
Create your free account to access the complete curriculum and knowledge assessments.
1.2 The regulatory framework: ICH E6(R3) Section 2.7, ICH E2A, and FDA requirements
Navigate the three regulatory frameworks governing safety reporting -- ICH E6(R3) principles, ICH E2A definitions, and FDA enforcement requirements under 21 CFR 312.
1.3 The CRC's role in the safety reporting chain
Define the CRC's specific safety reporting responsibilities and the critical boundaries between the CRC, investigator, sponsor, and IRB roles.
1.4 Definitions that matter: adverse event, serious adverse event, SUSAR, and the distinctions between them
Master the precise definitions of AE, SAE, and SUSAR and the four independent dimensions of adverse event classification that every CRC must understand.
4 lessons · 180 min
2.1 Eliciting adverse events: open-ended questioning techniques
Master the systematic approach to AE elicitation using open-ended questioning, body system review, and strategies to overcome participant barriers to reporting.
2.2 Physical assessment and vital sign changes as AE indicators
Learn when vital sign changes and physical examination findings become reportable adverse events through clinical significance assessment and protocol-specific thresholds.
2.3 Laboratory abnormalities: when a lab value becomes an adverse event
Apply the decision framework for determining when laboratory abnormalities constitute reportable adverse events, including clinical significance assessment and protocol-specific toxicity grading.
2.4 Between-visit AE identification: phone contacts, participant diaries, and spontaneous reports
Master the methods for identifying adverse events between study visits through structured telephone contacts, diary review, and spontaneous report handling, including the critical awareness date concept.
4 lessons · 180 min
3.1 Severity grading: CTCAE and protocol-specific grading scales
Master the CTCAE severity grading framework and protocol-specific grading scales, applying term-specific criteria to common adverse events encountered in clinical trials.
3.2 Seriousness criteria: the SAE triggers you must know
Apply the seven SAE seriousness criteria in operational depth, including the important medical event clause and hospitalization nuances that challenge even experienced CRCs.
3.3 Expectedness: the Investigator's Brochure as your reference
Understand how expectedness is assessed against the Investigator's Brochure reference safety information and why accurate event description by the CRC enables this critical determination.
3.4 Causality assessment: the investigator's judgment and the CRC's contribution
Understand the six factors in causality assessment, the CRC's critical role in information gathering, and common pitfalls that compromise the accuracy of this determination.
4 lessons · 180 min
4.1 The AE source document: what to capture and how to capture it
Master the essential data elements, structured approaches, and longitudinal documentation practices for adverse event source records that support regulatory reporting and participant safety.
4.2 AE CRF completion: onset, resolution, severity, action taken, and outcome
Complete adverse event CRF fields accurately with proper conventions for medical terminology, date formats, severity grading, and outcome coding that support reliable MedDRA coding and regulatory analysis.
4.3 Narrative descriptions that tell the clinical story
Write concise, chronological AE narratives that convey clinical context for regulatory review, distinguishing effective narratives from common documentation failures.
4.4 Concomitant medication documentation in the context of safety reporting
Document concomitant medications that support causality assessment, cross-reference AE and medication records, and handle complex scenarios including rescue medications and self-administered OTC therapies.
4 lessons · 180 min
5.1 Recognizing an SAE: the moment awareness triggers the clock
Understand the precise definition of site awareness, identify scenarios that start the SAE reporting clock, and execute the immediate actions required upon recognizing a serious adverse event.
5.2 Initial SAE reporting: the 24-hour timeline and what the initial report must contain
Execute the 24-hour SAE reporting timeline from awareness to submission, including minimum required data elements, partial report strategies, and handling common challenges like unavailable investigators.
5.3 SAE follow-up reports: updates, resolution, and final outcomes
Maintain the SAE reporting cycle from initial report through follow-up updates to final narrative, tracking open events until resolution and producing comprehensive documentation for regulatory review.
5.4 SAE reporting for different scenarios: hospitalizations, deaths, and pregnancy
Apply SAE reporting procedures to specific clinical scenarios including hospitalization nuances, death reporting requirements, pregnancy reporting pathways, and protocol-defined events of special interest.
4 lessons · 180 min
6.1 Investigator's Brochure updates: what changed and what it means for your site
Process IB amendments using a structured workflow that ensures safety-relevant changes trigger appropriate downstream actions including consent updates, expectedness reclassification, and monitoring adjustments.
6.2 Sponsor safety letters and CIOMS/MedWatch reports
Process sponsor safety communications including IND safety reports, CIOMS forms, and MedWatch reports through a structured workflow that ensures investigator review, team notification, and appropriate IRB reporting.
6.3 DSMB and DMC communications: when the data monitoring committee speaks
Understand the DSMB's role in participant protection, process its four recommendation types with appropriate site-level actions, and maintain blinding integrity throughout.
6.4 IRB/IEC reporting of safety information: meeting your institutional obligations
Navigate dual reporting obligations to sponsor and IRB with different timelines, forms, and information requirements.
4 lessons · 180 min
7.1 Safety reporting training for the site team: what everyone needs to know
Design role-specific safety reporting training for every study team member, from investigators to administrative staff, ensuring everyone knows their part in the safety chain.
7.2 Safety reporting systems: tracking, reminders, and quality checks
Build tracking systems, reminder workflows, and quality checks that ensure no safety obligation falls through the cracks at your site.
7.3 Learning from safety events: using AE patterns to improve participant care
Analyze patterns in adverse event data at the site level to identify potential issues, improve participant care, and share safety learnings across the study team.
7.4 The intersection of safety reporting and quality management
Connect safety reporting to the quality management framework, applying CAPA to safety failures and understanding how safety culture drives quality culture at your site.
1.2 The regulatory framework: ICH E6(R3) Section 2.7, ICH E2A, and FDA requirements
Navigate the three regulatory frameworks governing safety reporting -- ICH E6(R3) principles, ICH E2A definitions, and FDA enforcement requirements under 21 CFR 312.
1.3 The CRC's role in the safety reporting chain
Define the CRC's specific safety reporting responsibilities and the critical boundaries between the CRC, investigator, sponsor, and IRB roles.
1.4 Definitions that matter: adverse event, serious adverse event, SUSAR, and the distinctions between them
Master the precise definitions of AE, SAE, and SUSAR and the four independent dimensions of adverse event classification that every CRC must understand.
4 lessons · 180 min
2.1 Eliciting adverse events: open-ended questioning techniques
Master the systematic approach to AE elicitation using open-ended questioning, body system review, and strategies to overcome participant barriers to reporting.
2.2 Physical assessment and vital sign changes as AE indicators
Learn when vital sign changes and physical examination findings become reportable adverse events through clinical significance assessment and protocol-specific thresholds.
2.3 Laboratory abnormalities: when a lab value becomes an adverse event
Apply the decision framework for determining when laboratory abnormalities constitute reportable adverse events, including clinical significance assessment and protocol-specific toxicity grading.
2.4 Between-visit AE identification: phone contacts, participant diaries, and spontaneous reports
Master the methods for identifying adverse events between study visits through structured telephone contacts, diary review, and spontaneous report handling, including the critical awareness date concept.
4 lessons · 180 min
3.1 Severity grading: CTCAE and protocol-specific grading scales
Master the CTCAE severity grading framework and protocol-specific grading scales, applying term-specific criteria to common adverse events encountered in clinical trials.
3.2 Seriousness criteria: the SAE triggers you must know
Apply the seven SAE seriousness criteria in operational depth, including the important medical event clause and hospitalization nuances that challenge even experienced CRCs.
3.3 Expectedness: the Investigator's Brochure as your reference
Understand how expectedness is assessed against the Investigator's Brochure reference safety information and why accurate event description by the CRC enables this critical determination.
3.4 Causality assessment: the investigator's judgment and the CRC's contribution
Understand the six factors in causality assessment, the CRC's critical role in information gathering, and common pitfalls that compromise the accuracy of this determination.
4 lessons · 180 min
4.1 The AE source document: what to capture and how to capture it
Master the essential data elements, structured approaches, and longitudinal documentation practices for adverse event source records that support regulatory reporting and participant safety.
4.2 AE CRF completion: onset, resolution, severity, action taken, and outcome
Complete adverse event CRF fields accurately with proper conventions for medical terminology, date formats, severity grading, and outcome coding that support reliable MedDRA coding and regulatory analysis.
4.3 Narrative descriptions that tell the clinical story
Write concise, chronological AE narratives that convey clinical context for regulatory review, distinguishing effective narratives from common documentation failures.
4.4 Concomitant medication documentation in the context of safety reporting
Document concomitant medications that support causality assessment, cross-reference AE and medication records, and handle complex scenarios including rescue medications and self-administered OTC therapies.
4 lessons · 180 min
5.1 Recognizing an SAE: the moment awareness triggers the clock
Understand the precise definition of site awareness, identify scenarios that start the SAE reporting clock, and execute the immediate actions required upon recognizing a serious adverse event.
5.2 Initial SAE reporting: the 24-hour timeline and what the initial report must contain
Execute the 24-hour SAE reporting timeline from awareness to submission, including minimum required data elements, partial report strategies, and handling common challenges like unavailable investigators.
5.3 SAE follow-up reports: updates, resolution, and final outcomes
Maintain the SAE reporting cycle from initial report through follow-up updates to final narrative, tracking open events until resolution and producing comprehensive documentation for regulatory review.
5.4 SAE reporting for different scenarios: hospitalizations, deaths, and pregnancy
Apply SAE reporting procedures to specific clinical scenarios including hospitalization nuances, death reporting requirements, pregnancy reporting pathways, and protocol-defined events of special interest.
4 lessons · 180 min
6.1 Investigator's Brochure updates: what changed and what it means for your site
Process IB amendments using a structured workflow that ensures safety-relevant changes trigger appropriate downstream actions including consent updates, expectedness reclassification, and monitoring adjustments.
6.2 Sponsor safety letters and CIOMS/MedWatch reports
Process sponsor safety communications including IND safety reports, CIOMS forms, and MedWatch reports through a structured workflow that ensures investigator review, team notification, and appropriate IRB reporting.
6.3 DSMB and DMC communications: when the data monitoring committee speaks
Understand the DSMB's role in participant protection, process its four recommendation types with appropriate site-level actions, and maintain blinding integrity throughout.
6.4 IRB/IEC reporting of safety information: meeting your institutional obligations
Navigate dual reporting obligations to sponsor and IRB with different timelines, forms, and information requirements.
4 lessons · 180 min
7.1 Safety reporting training for the site team: what everyone needs to know
Design role-specific safety reporting training for every study team member, from investigators to administrative staff, ensuring everyone knows their part in the safety chain.
7.2 Safety reporting systems: tracking, reminders, and quality checks
Build tracking systems, reminder workflows, and quality checks that ensure no safety obligation falls through the cracks at your site.
7.3 Learning from safety events: using AE patterns to improve participant care
Analyze patterns in adverse event data at the site level to identify potential issues, improve participant care, and share safety learnings across the study team.
7.4 The intersection of safety reporting and quality management
Connect safety reporting to the quality management framework, applying CAPA to safety failures and understanding how safety culture drives quality culture at your site.